Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

Conclusions We hypothesize that the invasive strategy will improve outcomes in frail elderly patients with NSTEMI. If this is confirmed, frailty status should not dissuade physicians from implementing an invasive management strategy.This trial was registered at ClinicalTrials.gov (Identifier: NCT03208153).
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research